Last reviewed · How we verify

NCT03829904

The Effect of Traditional Chinese Medicine on Benign Prostatic Hyperplasia

Completed Phase 1, PHASE2 Last updated 13 April 2020
What this trial tests

Phase 1, PHASE2 trial testing VGH-BPH1 in Benign Prostatic Hyperplasia in 23 participants. Completed in 2 January 2020.

Timeline
6 March 2019
Primary endpoint
2 January 2020
2 January 2020

Quick facts

Lead sponsorTaipei Veterans General Hospital, Taiwan
PhasePhase 1, PHASE2
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingdouble
Primary purposetreatment
Enrollment23
Start date6 March 2019
Primary completion2 January 2020
Estimated completion2 January 2020
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Taipei Veterans General Hospital, Taiwan

Who can join

Eligibility, male only, with Benign Prostatic Hyperplasia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized, double-blinded, placebo-controlled, crossover clinical trial aims to investigate the effect of VGH-BPH1, a scientific Chinese medicine powder prescription, on patients with benign prostatic hyperplasia.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Efficacy evaluation of Chinese herbal medicine, VGH-BPH1, for patients with benign prostatic hyperplasia: A randomized, double-blind, placebo-controlled, and crossover study.
    Tran DNH, Yeh HF, Huang WJ, Wu PW, et al · · 2022 · cited 2× · PMID 35385425 · DOI 10.1097/jcma.0000000000000717

Verify or expand the search:

Other recruiting trials for Benign Prostatic Hyperplasia

Currently open trials in the same condition.

Other Taipei Veterans General Hospital, Taiwan trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03829904.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing